Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Debt / NOTE 1.500% 6/1
-
Number of holders
-
17
-
Total principal
-
167M
-
Principal change
-
+167M
-
Total reported value, excl. options
-
$164M
-
Value change
-
+$164M
-
Number of buys
-
17
-
Price
-
$0.98
Significant Holders of IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 as of Q3 2020
17 filings reported holding 46333XAH1 - IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 as of Q3 2020.
IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 has 17 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $167M of principal
.
Largest 10 bondholders include CITADEL ADVISORS LLC ($52.8M of principal), CAMDEN ASSET MANAGEMENT L P /CA ($35.2M of principal), LAZARD ASSET MANAGEMENT LLC ($15M of principal), Polar Asset Management Partners Inc. ($14.5M of principal), Linden Advisors LP ($11.5M of principal), CALAMOS ADVISORS LLC ($9.5M of principal), CNH PARTNERS LLC ($5.5M of principal), SUSQUEHANNA INTERNATIONAL GROUP, LLP ($5.37M of principal), Jefferies Group LLC ($5.15M of principal), and SHENKMAN CAPITAL MANAGEMENT INC ($3.44M of principal).
This table shows the top 17 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.